Literature DB >> 25218335

Selectins and platelet-derived growth factor (PDGF) in schistosomiasis-associated pulmonary hypertension.

Monica Lapa1, Milena M P Acencio, Alberto Q Farias, Lisete R Teixeira, Caio J C Fernandes, Carlos P Jardim, Mario Terra-Filho.   

Abstract

PURPOSE: The aim of this study was to evaluate the expression profiles of the relevant selectins and PDGF in schistosomiasis-associated pulmonary hypertension.
METHODOLOGY: Patients with three distinct clinical profiles were enrolled in the study: IPAH(n = 11), schistosomiasis-associated PH (Sch-PH))(n = 13), and schistosomiasis without PH (Sch) (n = 13). Healthy volunteers, were recruited as a control group(n = 13). Echocardiography was performed in all groups, and the PH patients underwent right heart catheterization. Plasma soluble adhesion molecules E- and P-Selectin, PDGF-AB, PDGF-BB were determined by ELISA.
RESULTS: E-selectin was significantly increased in the IPAH group compared with the other groups [the control, Sch + PH and Sch groups) (p < 0.001) (Fig. 2)]. P-selectin was lower in Sch (20.2 + 8.9 × 103 pg/mL) as compared to the control, (43 16.8 × 103 pg/mL), IPAH (35.8 7.8 × 103 pg/mL), and Sch + PH (36.8 ± 15.7 × 103 pg/mL) (p = 0.005) groups. Serum PDGF-BB levels were higher in the control group (8.9 ± 4.8 × 103 pg/mL) compared with the IPAH (3.7 ± 2.17 × 103 pg/mL), Sch + PH (5.2 ± 3.7 × 103 pg/mL) and Sch (2.4 ± 1.7 × 103 pg/mL) groups (p < 0.05). PDGF-AB levels were also higher in the control group (25.6 ± 8.6 × 103 pg/mL), compared with the other three groups, being the Sch group the one with lower serum levels of this marker (11.4 ± 8.6 × 103 pg/mL) (p = 0.006).
CONCLUSIONS: In conclusion, vascular inflammation in schistosomiasis, with or without PH, is different from IPAH suggesting distinct pathophysiological mechanisms associated with the development of pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218335     DOI: 10.1007/s00408-014-9643-0

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  28 in total

1.  Survival in schistosomiasis-associated pulmonary arterial hypertension.

Authors:  Caio Julio Cesar dos Santos Fernandes; Carlos Vianna Poyares Jardim; Andre Hovnanian; Susana Hoette; Bruno Arantes Dias; Silvia Souza; Marc Humbert; Rogerio Souza
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

Review 2.  Update in pulmonary arterial hypertension 2007.

Authors:  Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2008-03-15       Impact factor: 21.405

Review 3.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 4.  Pathophysiology of portal hypertension.

Authors:  H Cichoz-Lach; K Celiński; M Słomka; B Kasztelan-Szczerbińska
Journal:  J Physiol Pharmacol       Date:  2008-08       Impact factor: 3.011

5.  Assessment of portal hemodynamics by Doppler ultrasound and of liver morphology in the hepatosplenic and hepatointestinal forms of schistosomiasis mansoni.

Authors:  Denise Cerqueira Paranaguá Vezozzo; Alberto Queiroz Farias; Giovanni Guido Cerri; Luiz Caetano Da Silva; Flair José Carrilho
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

6.  Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria.

Authors:  Eduardo Leite Vieira Costa; Carlos Jardim; Humberto Bassit Bogossian; Marcelo Britto Passos Amato; Carlos Roberto Ribeiro Carvalho; Rogerio Souza
Journal:  Vascul Pharmacol       Date:  2005-09       Impact factor: 5.773

7.  Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

Authors:  Frédéric Perros; David Montani; Peter Dorfmüller; Ingrid Durand-Gasselin; Colas Tcherakian; Jérôme Le Pavec; Michel Mazmanian; Elie Fadel; Sacha Mussot; Olaf Mercier; Philippe Hervé; Dominique Emilie; Saadia Eddahibi; Gérald Simonneau; Rogério Souza; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

Review 8.  Pulmonary arterial hypertension.

Authors:  Kelly M Chin; Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2008-04-22       Impact factor: 24.094

Review 9.  Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension).

Authors:  Rogério Souza; Caio Júlio César dos Santos Fernandes; Carlos Viana Poyares Jardim
Journal:  Semin Respir Crit Care Med       Date:  2009-07-24       Impact factor: 3.119

Review 10.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

View more
  3 in total

1.  Evidence of Accumulated Endothelial Progenitor Cells in the Lungs of Rats with Pulmonary Arterial Hypertension by 89Zr-oxine PET Imaging.

Authors:  Yimin Liu; Xin Zhao; Jie Ding; Yanjiang Xing; Meijun Zhou; Xuezhu Wang; Wenjia Zhu; Li Huo; Jun Yang
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-03       Impact factor: 6.698

2.  Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension.

Authors:  Susana Hoette; Claudia Figueiredo; Bruno Dias; Jose Leonidas Alves; Francisca Gavilanes; Luis Felipe Prada; Dany Jasinowodolinski; Luciana Tamie Kato Morinaga; Carlos Jardim; Caio Julio Cesar Fernandes; Rogério Souza
Journal:  BMC Pulm Med       Date:  2015-10-12       Impact factor: 3.317

3.  Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series).

Authors:  Wolfgang M Kuebler; Sébastien Bonnet; Arata Tabuchi
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.